Literature DB >> 7979987

Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat.

S K Sikder1, D Mitra, J Laurence.   

Abstract

One segment of the negative regulatory region of the human immunodeficiency virus long terminal repeat (HIV-LTR), nucleotides -273 to -255, is homologous to positive response elements for interleukin-2 and glucocorticoids. We demonstrate that this sequence, referred to as purine-rich response element (PRRE), acts as a classic enhancer in the context of a heterologous promoter, but serves as a functional repressor in the intact provirus, binding (a) cellular factor(s). These data suggest that certain DNA response elements in the HIV LTR serve as negative regulators only in the context of the intact LTR, presumably through interactions with other transcriptional factors, a phenomenon that might be exploited to interfere with viral gene transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979987     DOI: 10.1007/BF01311180

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay.

Authors:  B R Franza; S F Josephs; M Z Gilman; W Ryan; B Clarkson
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

2.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

Review 3.  Regulatory pathways governing HIV-1 replication.

Authors:  B R Cullen; W C Greene
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus-1: regulation by nef.

Authors:  B Guy; B Acres; M P Kieny; J P Lecocq
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Inhibition of tat-activated, HIV-1 long terminal repeat-mediated gene expression by glucocorticoids.

Authors:  D Mitra; S Sikder; J Laurence
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

7.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

8.  Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.

Authors:  H Soudeyns; R Geleziunas; G Shyamala; J Hiscott; M A Wainberg
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

9.  A novel T-cell protein which recognizes a palindromic sequence in the negative regulatory element of the human immunodeficiency virus long terminal repeat.

Authors:  K Orchard; N Perkins; C Chapman; J Harris; V Emery; G Goodwin; D Latchman; M Collins
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.

Authors:  J Laurence; L Mayer
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

View more
  3 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor-Activator Target Sequence of 5'-LTR.

Authors:  Ioannis Panagoulias; Fotios Karagiannis; Ioanna Aggeletopoulou; Tassos Georgakopoulos; Christos P Argyropoulos; Karolina Akinosoglou; Charalambos Gogos; Athanasios Skoutelis; Athanasia Mouzaki
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

3.  Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective?

Authors:  Andrew R McEwan; Alasdair MacKenzie
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.